In vivo relationship between synaptic density and functional connectivity in progressive supranuclear palsy: a multimodal [11C]UCB-J PET and resting state fMRI study.
Objective: To assess the relationship between synaptic density and functional connectivity in the primary tauopathy of Progressive Supranuclear Palsy (PSP). Background: PSP is a debilitating…Plasma microRNA expression profiling in patients with progressive supranuclear palsy. A five-microRNA panel in plasma was identified as a potential biomarker for progressive supranuclear palsy
Objective: Our objective was to identify differentially expressed, circulating miRNAs in PSP which could serve as diagnostic biomarker for this disease. Background: Progressive supranuclear palsy…Photophobia and Progressive Supranuclear Palsy
Objective: To characterize the prevalence, symptoms, and severity of light sensitivity in Progressive Supranuclear palsy (PSP)). Background: Photophobia is a commonly encountered clinical symptom in…MRI evaluation of Progressive Supranuclear Palsy
Objective: We aimed to evaluate the magnetic resonance imaging-derived parameters in differentiation of patients with progressive supranuclear palsy from patients with Parkinson’s disease and other…Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD
Objective: The midbrain-to-pons ratio (MTPR) is considered as an important diagnostic biomarker to differentiate between progressive supranuclear palsy (PSP) and idiopathic Parkinson’s disease (IPD). Here,…Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism
Objective: To determine diagnostic accuracy of P/M, MRPI, and new indices termed P/M2.0 and MRPI2.0 (multiplying P/M and MRPI by third ventricle width/frontal horns width…Niemann-Pick Type C Presenting as Progressive Supranuclear Palsy
Objective: We report a very old patient who presented the clinical features of progressive supranuclear palsy (PSP) including supranuclear vertical gaze palsy with prominent cerebellar…Progressive supranuclear palsy: Common metabolic pattern in different variants
Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a diagnosis of different PSP variants. Background: It remains unclear whether the supportive…The severity and distribution of tau pathology distinguish corticobasal degeneration and progressive supranuclear palsy
Objective: To elucidate whether the severity and distribution of tau pathology reflect the clinical presentations in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Background:…Gait and motion analysis in Progressive Supranuclear Palsy
Objective: Evaluate gait abnormalities in progressive supranuclear palsy (PSP) with three-dimensional motion analysis. Background: PSP is associated with complex, disabling gait and balance abnormalities that…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 38
- Next Page »